PEPTONIC medical AB (XSAT:PMED) Days Sales Outstanding : 34.90 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is PEPTONIC medical AB Days Sales Outstanding?

PEPTONIC medical AB's average Accounts Receivable for the three months ended in Mar. 2024 was kr4.13 Mil. PEPTONIC medical AB's Revenue for the three months ended in Mar. 2024 was kr10.81 Mil. Hence, PEPTONIC medical AB's Days Sales Outstanding for the three months ended in Mar. 2024 was 34.90.

The historical rank and industry rank for PEPTONIC medical AB's Days Sales Outstanding or its related term are showing as below:

XSAT:PMED' s Days Sales Outstanding Range Over the Past 10 Years
Min: 3.58 Med: 53.92 Max: 78.15
Current: 53.16

During the past 11 years, PEPTONIC medical AB's highest Days Sales Outstanding was 78.15. The lowest was 3.58. And the median was 53.92.

XSAT:PMED's Days Sales Outstanding is ranked better than
68.07% of 996 companies
in the Drug Manufacturers industry
Industry Median: 71.41 vs XSAT:PMED: 53.16

PEPTONIC medical AB's Days Sales Outstanding declined from Mar. 2023 (74.47) to Mar. 2024 (34.90).

PEPTONIC medical AB Days Sales Outstanding Historical Data

The historical data trend for PEPTONIC medical AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PEPTONIC medical AB Days Sales Outstanding Chart

PEPTONIC medical AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

12.05

3.58

59.59

51.90

55.93

PEPTONIC medical AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															74.47	-	-	55.57	34.90

Competitive Comparison of PEPTONIC medical AB's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, PEPTONIC medical AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PEPTONIC medical AB's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PEPTONIC medical AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where PEPTONIC medical AB's Days Sales Outstanding falls into.

PEPTONIC medical AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

PEPTONIC medical AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (7.242	+	4.134)	/	2 )	/	37.118	*	365
=	5.688					/	37.118	*	365
=	55.93

PEPTONIC medical AB's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (4.134	+	0)	/	1 )	/	10.808	*	365 / 4
=	4.134					/	10.808	*	365 / 4
=	34.90

PEPTONIC medical AB (XSAT:PMED) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

PEPTONIC medical AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of PEPTONIC medical AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

PEPTONIC medical AB (XSAT:PMED) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PEPTONIC medical AB (XSAT:PMED) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

28L:Germany

Address

Gustavslundsvägen 143, Bromma, SWE, SE-167 51

Website

https://www.peptonicmedical.se

PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.

PEPTONIC medical AB (XSAT:PMED) Headlines

No Headlines